FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lars Olsson

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Multicenter Studies

Activities & Behaviors

Walking

Co-author Network

Publications

TOP 3
Lars G Olsson; Karl Swedberg; John G F Cleland; Phillip Spark; Michel Komajda; Marco Metra; Christian Torp-Pedersen; Willem J Remme; Armin Scherhag; Philip A Poole-Wilson
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial.
Lars G Olsson; Karl Swedberg; Anique Ducharme; Christopher B Granger; Eric L Michelson; john mcmurray; Margareta Puu; Salim Yusuf; Marc A Pfeffer
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
Karl Swedberg; Lars G Olsson; Andrew Charlesworth; John G F Cleland; Peter Hanrath; Michel Komajda; Marco Metra; Christian Torp-Pedersen; Philip A Poole-Wilson
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lars Olsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Lars G Olsson; Karl Swedberg; John G F Cleland; Phillip Spark; Michel Komajda; Marco Metra; Christian Torp-Pedersen; Willem J Remme; Armin Scherhag; Philip A Poole-Wilson
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial.
European journal of heart failure 2007;9(8):795-801.
2006: Lars G Olsson; Karl Swedberg; Anique Ducharme; Christopher B Granger; Eric L Michelson; john mcmurray; Margareta Puu; Salim Yusuf; Marc A Pfeffer
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
Journal of the American College of Cardiology 2006;47(10):1997-2004.
2005: Karl Swedberg; Lars G Olsson; Andrew Charlesworth; John G F Cleland; Peter Hanrath; Michel Komajda; Marco Metra; Christian Torp-Pedersen; Philip A Poole-Wilson
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
European heart journal 2005;26(13):1303-8.
2005: Lars G Olsson; Karl Swedberg; Andrew L Clark; Klaus K Witte; John G F Cleland
Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review.
European heart journal 2005;26(8):778-93.